CONSTITUENT REPORT
Carvacrol
Carvacrol is a phenolic monoterpene most strongly associated with oregano, thyme chemotypes, and savory oils, where it contributes the hot medicinal pungency of strongly phenolic profiles. Compared with many archive constituents, it has a broad public literature base: identity and occurrence are clear, antimicrobial membrane-disruption research is well developed, anti-inflammatory studies are abundant in cell and animal models, and food-flavor safety evaluations from JECFA consider it of no safety concern at current flavoring intake levels. The evidence still leans heavily preclinical, so archive language should present carvacrol as a well-studied aromatic phenol with promising mechanism data and real irritation potential, not as a stand-alone medical treatment.
Chemical identity and composition
PubChem identifies carvacrol as C10H14O and the isomeric phenolic monoterpene 2-methyl-5-propan-2-ylphenol. In the archive it appears as a dominant chemotype driver rather than a minor trace constituent, reaching about 64.94-66.01% in oregano, 41.8% in thyme ct. carvacrol, and 32.83% in summer savory.
Aroma and practical use
- Use the recorded warm, spicy, phenolic, medicinal, oregano-like descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
A 1999 Applied and Environmental Microbiology study found that carvacrol rapidly reduced viable Bacillus cereus cells, depleted intracellular ATP, collapsed membrane potential, and increased proton and potassium permeability.
This is one of the clearest primary papers for carvacrol's antibacterial mechanism and remains widely cited for membrane-disruption and energy-collapse effects.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A 2013 mouse inflammation study reported that carvacrol reduced paw edema and lowered inflammatory mediators including IL-1beta and PGE2, with evidence pointing to IL-10 involvement.
The abstract describes anti-inflammatory effects in CFA-induced paw inflammation alongside cytokine and COX-2-related measurements.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A 2020 systematic review and meta-analysis concluded that carvacrol showed an overall anti-inflammatory and antioxidant effect across preclinical inflammatory-disease models.
The PubMed record summarizes reductions in multiple inflammatory cytokines and oxidative-stress markers across the included studies, reinforcing that the evidence is broad but still mostly preclinical.
This experimental finding does not establish benefit, dose or safety in people using this blend.
Food-safety evaluators at JECFA judged carvacrol to present no safety concern at current levels of intake when used as a flavouring agent.
This is intake-context flavor safety, not a carte blanche for concentrated topical or oral essential-oil use.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
Use concerns and concentration limits
Sensitization concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
A recorded constituent reference, not a recommended oil dilution. Product category, source applicability and all contributing oils must be checked before use.
unverified reference · No source provenance attachedJECFA lists carvacrol as presenting no safety concern at current flavoring intake levels, which supports food-flavor exposure context rather than undiluted therapeutic use.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
No direct public citation is attached to this entry.
Archive oil records and supplier safety notes consistently treat carvacrol-rich oils as skin-irritating phenolic materials that require strong dilution caution.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Because most benefit-facing data are cell, microbial, or animal studies, consumer-facing copy should avoid converting anti-inflammatory or antimicrobial findings into medical claims.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Constituents it may interact with
These are research candidates recorded in the interaction matrix. They do not add a proven-amplification bonus to the score.
ThymolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Thymol report →EugenolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Eugenol report →LinaloolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Linalool report →citralAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read citral report →1,8-cineoleAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read 1,8-cineole report →GeraniolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Geraniol report →gamma-TerpineneAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read gamma-Terpinene report →p-CymeneAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read p-Cymene report →MyrceneAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Myrcene report →FarnesolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Farnesol report →(E)-cinnamaldehydeAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read (E)-cinnamaldehyde report →NeralAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Neral report →geranialAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read geranial report →ThymolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · antioxidant
No source citation attached.
Read Thymol report →p-CymeneAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · whole_oil
No source citation attached.
Read p-Cymene report →LinaloolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · whole_oil
No source citation attached.
Read Linalool report →1,8-cineoleAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · whole_oil
No source citation attached.
Read 1,8-cineole report →NerolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Nerol report →alpha-TerpineneAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · whole_oil
No source citation attached.
Read alpha-Terpinene report →gamma-TerpineneAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · whole_oil
No source citation attached.
Read gamma-Terpinene report →alpha-TerpineneAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read alpha-Terpinene report →alpha-TerpineolAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read alpha-Terpineol report →LimoneneAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
in vitro · effect
No source citation attached.
Read Limonene report →alpha-Terpinyl acetateAmplification candidate
Candidate in the research matrix. A coefficient alone does not establish amplification at the dose, route or goal of your blend; no proven amplification is inferred from this row.
review · whole_oil
No source citation attached.
Read alpha-Terpinyl acetate report →How the effects were investigated
cytoplasmic membrane disruption with proton and potassium leakage
A landmark Bacillus cereus paper found that carvacrol dissipated membrane potential, depleted intracellular ATP, and increased permeability to protons and potassium ions.
This experimental finding does not establish benefit, dose or safety in people using this blend.
reduction of IL-1beta, prostanoids, and COX-2-linked inflammatory signaling
Mouse CFA-inflammation work reported reduced inflammatory mediators after carvacrol administration together with a key role for IL-10 in the observed anti-inflammatory response.
This experimental finding does not establish benefit, dose or safety in people using this blend.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (6)
- High-quality isolated-carvacrol human trials remain limited compared with the size of the cell and animal literature.
- This pass did not verify a public constituent-specific IFRA dermal maximum for isolated carvacrol itself, even though carvacrol-rich oils are consistently treated as strongly irritant.
- Several recent reviews are enthusiastic in tone; this record keeps the evidence weighted toward primary mechanism papers and safety evaluations to avoid overstating efficacy.
- The numeric dermal reference lacks source provenance; a verified flag alone is insufficient.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.
- Interaction candidates lack an attached source citation and remain unqualified.